CMP: 22

Ortin Laboratories Ltd. manufactures pharmaceuticals. The Company produces anti-arthritics, antibiotics, chemo therapeutics, analgesics and antipyretics, cardiac and cardiovascular drugs, anti-diarrhea drugs, anti-depressants, anti-hypertensive, anti-aids, anti-tuberculosis drugs, gynecological drugs, anti-diabetic drugs, antacids, nutritional supplements, and other products.

Ortin Laboratories is a 38 Crore penny cap stock. Its currently trading at a fair P/E of 20 and excellent dividend yields of over 3% in the last 12 months. Revenues have steadily risen from 12 Crores to 31 Crores in the last 5 years. Profits have picked up in similar lines from 0.25 Crores to 0.88 Crores. NPM has marginally improved from 2% to 3% over 5 years. The recent quarter Q1 FY12 has spiked both in revenues (100%) and profits (300%). Buy for long term gains.